Literature DB >> 11827726

Enhancement of hydralazine hypotension by low doses of isoniazid. Possible role of semicarbazide-sensitive amine oxidase inhibition.

H Vidrio1, M Medina, G Fernandez, M Lorenzana-Jimenez, A E Campos.   

Abstract

The influence of pretreatment with 1 through 300 mg/kg ip of isoniazid (ISO) on blood pressure and heart rate responses to 0.1 mg/kg iv of hydralazine (HYD) was assessed in rats anesthetized with chloralose--urethane. HYD hypotension was significantly enhanced by ISO at doses between 3 and 300 mg/kg ip. Heart rate was not influenced by HYD in control or pretreated animals. Depressor responses to 0.2 mg/kg iv of pinacidil (PIN) were also potentiated by ISO at 100 and 300, but not at 30 mg/kg. Similarly, ISO decreased cerebral gamma-aminobutyric acid (GABA) at the two highest doses; 30 mg/kg was without effect. Pretreatment of rats with ISO at 1 through 300 mg/kg failed to influence HYD-induced relaxation of aortic rings. These results were interpreted as indicating that potentiation of HYD hypotension by high doses of ISO is not specific for that vasodilator and is related to decreased cerebral GABA, as postulated previously. Lower doses could specifically potentiate the HYD-induced hypotensive effect by inhibition of semicarbazide-sensitive amine oxidase (SSAO), since both ISO and HYD are potent inhibitors of this enzyme. In support of this hypothesis, the SSAO inhibitors, benserazide (100 mg/kg ip) and mexiletine (50 mg/kg ip), were also found to enhance HYD hypotension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11827726     DOI: 10.1016/s0306-3623(01)00106-9

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Hypotensive effect of hydroxylamine, an endogenous nitric oxide donor and SSAO inhibitor.

Authors:  H Vidrio; M Medina
Journal:  J Neural Transm (Vienna)       Date:  2007-03-26       Impact factor: 3.575

3.  Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide.

Authors:  Bullo Saifullah; Palanisamy Arulselvan; Mohamed Ezzat El Zowalaty; Sharida Fakurazi; Thomas J Webster; Benjamin M Geilich; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2014-10-09

4.  Synthesis, characterization, and efficacy of antituberculosis isoniazid zinc aluminum-layered double hydroxide based nanocomposites.

Authors:  Bullo Saifullah; Mohamed Ezzat El Zowalaty; Palanisamy Arulselvan; Sharida Fakurazi; Thomas J Webster; Benjamin Mahler Geilich; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2016-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.